Clare Makepeace

Medical Science Liaison @UCB

London, GB

Developing KOL / healthcare professional relationships to understand needs and build an evidence base for drug application, with key focus initially on generalised epilepsy treatment and latterly on rare epilepsy syndromes, a niche, high-cost arena. Also oversee clinical trials, provide evidence-based support in identifying relevant cohorts, troubleshoot supply issues, and manage registration of physicians for controlled drug access. Lead engagement country-wide, expanding target areas to explore current treatment rationale and referral criteria for rare disease patients and facilitating peer to peer advocacy Identified opportunities for Investigator Initiated studies (IIS) and Real-World Evidence (RWE) data generation projects Achieved extensive interest in and resultant enactment of independent drug audit & case study series Oversee clinical trials and highlight potential sites for recruitment, promoting engagement Create and deliver disease awareness education to stakeholders to ensure relevant patient identification Provide training and guidance to nurses in drug administrationFenfluramine is now licenced for 2 indications in the UK, has NICE reimbursement status for 1 indication and is in the process of achieving reimbursement for the 2nd

De Montfort University

Non-Medical Prescribing BSc

De Montfort University

Consultation and Physical Examination Skills

Anglia Ruskin University

ENB N47, N997/998, Nursing Education

Birmingham City University

Nursing studies BSc, Registered Nursing/Registered Nurse

University of Leicester

Msc module, Counselling skills in Diabetes